Product image of Клопиксол-Акюфейз (Zuclopenthixol Acetate) supplied by GNH India

Клопиксол-Акюфейз

Active Ingredient:
Zuclopenthixol Acetate
Origin:
EU

Клопиксол-Акюфейз (Zuclopenthixol Acetate)

Клопиксол-Акюфейз (Zuclopenthixol Acetate) is an intramuscular antipsychotic injection for short-term management of acute agitation in schizophrenia and related conditions. This fast-acting formulation provides rapid symptom relief when oral medication is not feasible. Zuclopenthixol acetate injection helps stabilize patients during acute episodes. Zuclopenthixol acetate 50mg/ml injection is a trusted choice for emergency psychiatric care.

Manufacturer / TM Owner

Lundbeck Export A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Zuclopenthixol Acetate is primarily used for short-term treatment of acute agitation and behavioral disturbances in patients with schizophrenia and other psychotic disorders. It may also be used when rapid symptom control is needed and oral medication cannot be administered. This medication helps calm severe agitation while allowing for further assessment and treatment planning. Patients experiencing acute psychotic episodes often benefit from this intramuscular approach.

Side Effects

  • This medication works by affecting certain chemicals in the brain to help reduce agitation and psychotic symptoms. Patients typically experience a calming effect within hours of administration, which can help prevent escalation of aggressive behavior. The effects generally last for several days, providing time to establish longer-term treatment strategies. Some patients may feel drowsy or experience mild injection site discomfort.

Precautions & Warnings

  • Keep this medication refrigerated between 2°C and 8°C until use. It should only be administered by trained healthcare professionals in a clinical setting. Patients should be monitored for signs of excessive sedation or movement disorders after injection. Inform your healthcare provider about any history of heart conditions or seizures before receiving this medication.

Avoid Interactions

  • Zuclopenthixol Acetate may interact with alcohol and other central nervous system depressants, potentially increasing sedation. Combining with other antipsychotics or medications affecting heart rhythm should be done with caution. Certain blood pressure medications and antidepressants may also interact with this drug. Always inform your healthcare provider about all medications you're currently taking.

Frequently Asked Questions

It is used for short-term treatment of acute agitation in schizophrenia and related psychotic disorders when rapid symptom control is needed.

Effects typically begin within hours of intramuscular injection, with peak action occurring within 24-48 hours.

No, it is specifically designed for short-term use during acute episodes rather than ongoing treatment.

Patients should not drive or operate machinery until they know how this medication affects them.

Common effects may include drowsiness, injection site reactions, and mild movement-related symptoms.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Zuclopenthixol Acetate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT